New ICD-10-CM Codes in 2025

261 codes were added to the 2025 ICD-10-CM code set, effective October 1, 2024.

C81.0A - Nodular lymphocyte predominant Hodgkin lymphoma, in remission
C81.1A - Nodular sclerosis Hodgkin lymphoma, in remission
C81.2A - Mixed cellularity Hodgkin lymphoma, in remission
C81.3A - Lymphocyte depleted Hodgkin lymphoma, in remission
C81.4A - Lymphocyte-rich Hodgkin lymphoma, in remission
C81.7A - Other Hodgkin lymphoma, in remission
C81.9A - Hodgkin lymphoma, unspecified, in remission
C82.0A - Follicular lymphoma grade I, in remission
C82.1A - Follicular lymphoma grade II, in remission
C82.2A - Follicular lymphoma grade III, unspecified, in remission
C82.3A - Follicular lymphoma grade IIIa, in remission
C82.4A - Follicular lymphoma grade IIIb, in remission
C82.5A - Diffuse follicle center lymphoma, in remission
C82.6A - Cutaneous follicle center lymphoma, in remission
C82.8A - Other types of follicular lymphoma, in remission
C82.9A - Follicular lymphoma, unspecified, in remission
C83.0A - Small cell B-cell lymphoma, in remission
C83.1A - Mantle cell lymphoma, in remission
C83.390 - Primary central nervous system lymphoma
C83.398 - Diffuse large B-cell lymphoma of other extranodal and solid organ sites
C83.3A - Diffuse large B-cell lymphoma, in remission
C83.5A - Lymphoblastic (diffuse) lymphoma, in remission
C83.7A - Burkitt lymphoma, in remission
C83.8A - Other non-follicular lymphoma, in remission
C83.9A - Non-follicular (diffuse) lymphoma, unspecified, in remission
C84.0A - Mycosis fungoides, in remission
C84.1A - Sézary disease, in remission
C84.4A - Peripheral T-cell lymphoma, not elsewhere classified, in remission
C84.6A - Anaplastic large cell lymphoma, ALK-positive, in remission
C84.7B - Anaplastic large cell lymphoma, ALK-negative, in remission
C84.9A - Mature T/NK-cell lymphomas, unspecified, in remission
C84.AA - Cutaneous T-cell lymphoma, unspecified, in remission
C84.ZA - Other mature T/NK-cell lymphomas, in remission
C85.1A - Unspecified B-cell lymphoma, in remission
C85.2A - Mediastinal (thymic) large B-cell lymphoma, in remission
C85.8A - Other specified types of non-Hodgkin lymphoma, in remission
C85.9A - Non-Hodgkin lymphoma, unspecified, in remission
C86.00 - Extranodal NK/T-cell lymphoma, nasal type not having achieved remission
C86.01 - Extranodal NK/T-cell lymphoma, nasal type, in remission
C86.10 - Hepatosplenic T-cell lymphoma not having achieved remission
C86.11 - Hepatosplenic T-cell lymphoma, in remission
C86.20 - Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission
C86.21 - Enteropathy-type (intestinal) T-cell lymphoma, in remission
C86.30 - Subcutaneous panniculitis-like T-cell lymphoma not having achieved remission
C86.31 - Subcutaneous panniculitis-like T-cell lymphoma, in remission
C86.40 - Blastic NK-cell lymphoma not having achieved remission
C86.41 - Blastic NK-cell lymphoma, in remission
C86.50 - Angioimmunoblastic T-cell lymphoma not having achieved remission
C86.51 - Angioimmunoblastic T-cell lymphoma, in remission
C86.60 - Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
C86.61 - Primary cutaneous CD30-positive T-cell proliferations, in remission
C88.00 - Waldenström macroglobulinemia not having achieved remission
C88.01 - Waldenström macroglobulinemia, in remission
C88.20 - Heavy chain disease not having achieved remission
C88.21 - Heavy chain disease, in remission
C88.30 - Immunoproliferative small intestinal disease not having achieved remission
C88.31 - Immunoproliferative small intestinal disease, in remission
C88.40 - Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission
C88.41 - Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], in remission
C88.80 - Other malignant immunoproliferative diseases not having achieved remission
C88.81 - Other malignant immunoproliferative diseases, in remission
C88.90 - Malignant immunoproliferative disease, unspecified not having achieved remission
C88.91 - Malignant immunoproliferative disease, unspecified, in remission
D61.03 - Fanconi anemia
E10.A - Type 1 diabetes mellitus, presymptomatic
E10.A0 - Type 1 diabetes mellitus, presymptomatic, unspecified
E10.A1 - Type 1 diabetes mellitus, presymptomatic, Stage 1
E10.A2 - Type 1 diabetes mellitus, presymptomatic, Stage 2
E16.A - Hypoglycemia level
E16.A1 - Hypoglycemia level 1
E16.A2 - Hypoglycemia level 2
E16.A3 - Hypoglycemia level 3
E34.00 - Carcinoid syndrome, unspecified
E34.01 - Carcinoid heart syndrome
E34.09 - Other carcinoid syndrome
E66.81 - Obesity class
E66.811 - Obesity, class 1
E66.812 - Obesity, class 2
E66.813 - Obesity, class 3
E66.89 - Other obesity not elsewhere classified
E74.82 - Disorders of citrate metabolism
E74.820 - SLC13A5 Citrate Transporter Disorder
E74.829 - Other disorders of citrate metabolism
E88.82 - Obesity due to disruption of MC4R pathway
F50.010 - Anorexia nervosa, restricting type, mild
F50.011 - Anorexia nervosa, restricting type, moderate
F50.012 - Anorexia nervosa, restricting type, severe
F50.013 - Anorexia nervosa, restricting type, extreme
F50.014 - Anorexia nervosa, restricting type, in remission
F50.019 - Anorexia nervosa, restricting type, unspecified
F50.020 - Anorexia nervosa, binge eating/purging type, mild
F50.021 - Anorexia nervosa, binge eating/purging type, moderate
F50.022 - Anorexia nervosa, binge eating/purging type, severe
F50.023 - Anorexia nervosa, binge eating/purging type, extreme
F50.024 - Anorexia nervosa, binge eating/purging type, in remission
F50.029 - Anorexia nervosa, binge eating/purging type, unspecified
F50.20 - Bulimia nervosa, unspecified
F50.21 - Bulimia nervosa, mild
F50.22 - Bulimia nervosa, moderate
F50.23 - Bulimia nervosa, severe